Table 2. Final diagnosis of propensity-matched patients.
Final diagnosis | n (%) |
Adenocarcinoma | 141 (74.2 %) |
NET | 10 (5.3 %) |
SPN | 10 (5.3 %) |
Metastatic pancreatic tumor | 4 (2.1 %) |
Acinar cell carcinoma | 3 (1.6 %) |
Benign lesions | 22 (11.6 %) |
Overall | 190 (100 %) |
n, number of lesions; NET, neuroendocrine tumor; SPN, solid pseudopapillary neoplasm